Genetic Technologies raising $8.1M for cancer risk assessment tests
Genetic Technologies (ASX:GTG) has received commitments to raise $8.1 million from professional and sophisticated investors in the U.S. at $0.0113 per share.
Company
Genetic Technologies Limited
ASX:GTG
Genetic Technologies Ltd (ASX:GTG; NASDAQ:GENE) is a diversified molecular diagnostics company. The company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world.
67 stories · page 3 of 4